It is Teva's second major acquisition in recent months. In late July it agreed to pay $40.5 billion in cash and stock for Allergan's generics drug business to solidify its position as the world's No. 1 maker of generic drugs. With the Rimsa deal ...
Reuters · 10/1/2015
Teva Pharm
This is Teva's second mutli-billion acquisition is the past three months after it agreed to acquire the generic business of Allergan plc ( AGN) in a $40.5 billion cash and stock deal in late July. The deal will cement Teva's position as the world's largest ...
NASDAQ · 10/1/2015
In the informal parlance of the trading pits, this stock is red hot. For starters, Eagle entered into an exclusive licensing agreement in February with Teva Pharmaceutical Industries (TEVA) for its injectable drug. And even …
USNews · 10/5/2015
small businesses
The deal comes just two months after the Jerusalem-based company offered to buy Allergan's generics drug business for $40.5 billion in cash and stock. (See: Teva in $40.5-bn pact to buy Allergan's generics, ends …
Domain-b · 10/3/2015
Teva Pharmaceutical
McCormick stock is down 4% today. The company earned 85 cents per share in the latest quarter, on an adjusted basis, which was 2 cents short of analyst expectations. Revenue was higher than forecast. McCormick …
Barron's · ByDimitra Defotis · 10/2/2015
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) announced today the approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) of once-daily COPAXONE ® (glatiramer acetate injection) 20mg injection for the prevention of …
Stockhouse · 9/28/2015
For most of this year, Teva, Mylan Inc (NASDAQ:MYL), Shire and Perrigo have been duking it out. Mylan made a hostile bid for Perrigo, but Perrigo fended that bid off by acquiring part of GlaxoSmithKline's European …
Value Walk · 10/3/2015
Teva Pharmaceutical Industries Ltd's drug ... About 5.8 million shares traded, more than four times the stock's 25-day average. (Reporting By Samantha Kareen Nair in Bengaluru; Editing by Sriraj Kalluvila)
Yahoo News · 1 day ago
neurological disorder
The stock was sold at an average price of $62.78 ... The Company markets its products Sanuk, Teva, and UGG. The UGG brand supplies a line of footwear, with merchandise offerings to children, men and women. Teva is its lifestyle brand that is lively. · 1 day ago
Deckers Outdoor Corp
Teva Pharmaceutical Industries Ltd. launched a $40 billion bid for Mylan NV, bringing into focus the latest battle lines in a fight for heft in the drug industry. Teva, an Israeli company that says its medicines account for one out of every eight ...
Wall Street Journal · ByJonathan D. Rockoff · 4/21/2015

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes prim…
Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and to a lesser extent proprietary pharmaceuticals. It is the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide. Teva's facilities are located in Israel, North America, Europe, and South America. Teva is a member of both the New York Stock Exchange and the Tel Aviv Stock Exchange.
Data from: Wikipedia